- Home
- RPRX vs PNW Comparison
RPRX vs PNW Comparison
Compare RPRX & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- PNW
- Stock Information
- Founded
- RPRX 1996
- PNW 1985
- Country
- RPRX United States
- PNW United States
- Employees
- RPRX N/A
- PNW N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- PNW Electric Utilities: Central
- Sector
- RPRX Health Care
- PNW Utilities
- Exchange
- RPRX Nasdaq
- PNW Nasdaq
- Market Cap
- RPRX 11.7B
- PNW 9.7B
- IPO Year
- RPRX 2020
- PNW N/A
- Fundamental
- Price
- RPRX $25.23
- PNW $85.61
- Analyst Decision
- RPRX Strong Buy
- PNW Buy
- Analyst Count
- RPRX 6
- PNW 13
- Target Price
- RPRX $41.67
- PNW $84.50
- AVG Volume (30 Days)
- RPRX 3.2M
- PNW 1.1M
- Earning Date
- RPRX 02-13-2025
- PNW 11-06-2024
- Dividend Yield
- RPRX 3.33%
- PNW 4.18%
- EPS Growth
- RPRX 518.56
- PNW 27.39
- EPS
- RPRX 2.55
- PNW 5.34
- Revenue
- RPRX $2,266,003,000.00
- PNW $5,021,081,000.00
- Revenue This Year
- RPRX $12.21
- PNW $6.05
- Revenue Next Year
- RPRX $11.13
- PNW $2.71
- P/E Ratio
- RPRX $9.88
- PNW $16.02
- Revenue Growth
- RPRX N/A
- PNW 6.52
- 52 Week Low
- RPRX $24.05
- PNW $65.20
- 52 Week High
- RPRX $31.66
- PNW $95.42
- Technical
- Relative Strength Index (RSI)
- RPRX 43.88
- PNW 36.09
- Support Level
- RPRX $24.05
- PNW $83.97
- Resistance Level
- RPRX $25.28
- PNW $93.23
- Average True Range (ATR)
- RPRX 0.55
- PNW 1.61
- MACD
- RPRX 0.00
- PNW -0.58
- Stochastic Oscillator
- RPRX 46.46
- PNW 17.71
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.